Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. - Wikidata - awgldk - TriplyDB

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

http://www.wikidata.org/entity/Q35995568

about

Insomnia pharmacotherapy Insomnia Strategic opportunities in sleep and circadian research: report of the Joint Task Force of the Sleep Research Society and American Academy of Sleep Medicine Implementation of Sleep and Circadian Science: Recommendations from the Sleep Research Society and National Institutes of Health Workshop The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial Effects of anesthesia on the response to sleep deprivation The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study.A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia Why treat insomnia?Benzodiazepine receptor agonists cause drug-specific and state-specific alterations in EEG power and acetylcholine release in rat pontine reticular formation Management of Hypnotic Discontinuation in Chronic Insomnia.Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats.Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo.Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.Aerobic exercise improves self-reported sleep and quality of life in older adults with insomnia Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study Neuropharmacology of Sleep and Wakefulness.Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.Insomnia and the performance of US workers: results from the America insomnia survey.The association of fatigue with depression and insomnia in HIV-seropositive patients: a pilot study.Patient Background Factors Affecting the Therapeutic Outcomes in Response to Eszopiclone in Adult Patients with Chronic Insomnia: A Post Hoc Analysis of a Double-Blind Phase III Study in Japan.Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.Neuropharmacology of Sleep and Wakefulness: 2012 Update.Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity.Quality of life in patients suffering from insomnia Eszopiclone versus zopiclone in the treatment of insomnia.Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.Relationship between sleep disturbance and recovery in patients with borderline personality disorder An approach to long-term sedative-hypnotic use A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial.Measures of sleep in rheumatologic diseases: Epworth Sleepiness Scale (ESS), Functional Outcome of Sleep Questionnaire (FOSQ), Insomnia Severity Index (ISI), and Pittsburgh Sleep Quality Index (PSQI).Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia Optimizing the Pharmacologic Treatment of Insomnia: Current Status and Future Horizons Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.Sleep duration and health-related quality of life among older adults: a population-based cohort in Spain.Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs.Algorithms for the assessment and management of insomnia in primary care.

P2860

Q24623757-A25D69CD-3991-4177-B949-556E3930C886 Q24632498-E36AA1B7-4B61-444F-8C2E-6B7FE19646A7 Q26858809-5A854271-A52F-486C-B742-84C4E8F078A7 Q28393831-F0056ACB-C04B-464C-972F-3C5A2359D474 Q30301208-9383D3C8-D93D-4A16-BF19-7A43A6DF1B63 Q30475357-D46775EA-E095-4945-86F9-DEB97CB6E2C7 Q33586991-57B08E0F-C94F-47B1-A4F1-3CF1E05F9963 Q33587570-2D28ADAD-6E69-49DA-9D2C-84DACFA343DB Q33635442-71FD49EF-D2A4-49BC-BA19-6BD93E8FC093 Q33902276-F9F66B7B-613B-4AB9-B7A6-B279897F3D0B Q33950189-8A9EBCB5-7E50-4E44-821E-8DBE95CB7B9F Q33958179-74396ABF-BA07-4084-A95D-7EF395A690DC Q34061181-E1801925-23E3-4235-ADC9-8CE1AE36896C Q34086489-2FCC7394-1728-4BF2-9511-3FEC48D024B4 Q34197699-70546434-A28A-4B03-B54E-CE00608B7824 Q34355630-54CC4EA7-E6DE-4755-9CB4-E895622BF2FA Q34500442-E9BF4C08-D76C-401D-9F32-1E1AC923D0C2 Q34518670-2CCF6C71-C8D8-4FCF-834B-D58A32B077D2 Q35016391-A6642B9A-2F05-4C4B-B1A6-A8B9541E8CA4 Q35169400-314A2EA6-D663-43B6-B7F1-48FD3D57A083 Q35529548-926F7100-6658-4669-B8F9-1C8B773061EE Q36090682-F05DB9FA-720D-4177-939C-F6F7621A3F5F Q36198401-6E18A120-DE45-48E2-998C-49136531EDD9 Q36304821-E28104AC-C49E-43BE-B38B-B34E5C505AE6 Q36393701-939DF8B1-1B22-4BBE-9D4A-6FB3E496BAB3 Q36419739-828EE82F-B0D2-40AD-B6DC-039C085BE7B1 Q36430588-F88CA945-18ED-46E2-968A-008961FA3B93 Q36518854-B8F984E6-CBE2-4D6A-B932-B3DAAB191B04 Q36637811-8C09B195-0BA0-46AF-8996-11A4A60AA210 Q36701876-EBCF94B1-D1A2-4A1A-932F-C83CD3218925 Q36779890-102977A2-BDF0-4B1F-8FF7-66537A22ECAD Q36897384-25FBE368-C62E-49B5-AD0F-C8CC0A811656 Q36948426-3642FBBB-CCDB-45CB-A98B-C330990CD7B7 Q37011902-7784E809-7DE0-41CA-AD6F-F152D9B9F599 Q37109731-792966C0-E7EA-4528-9C89-1701C173CDEC Q37149325-EE83AE5A-B8CC-49BB-B8E2-79562603DAD8 Q37212670-16943AA7-4566-4B62-A13A-2335D3F3E6DB Q37279102-D1F92B19-E7CA-4B01-BB79-5828893C6485 Q37301240-306B6935-7DA0-404D-AAFD-C0F76EC4164D Q37423760-067BD145-A48E-405A-AC4D-D27D28FC2796

P2860

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

http://www.wikidata.org/entity/Q35995568

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Nightly treatment of primary i ...... of life, and work limitations.

@ast

Nightly treatment of primary i ...... of life, and work limitations.

@en

type

label

Nightly treatment of primary i ...... of life, and work limitations.

@ast

Nightly treatment of primary i ...... of life, and work limitations.

@en

prefLabel

Nightly treatment of primary i ...... of life, and work limitations.

@ast

Nightly treatment of primary i ...... of life, and work limitations.

@en

P1433

Q35995568-78292641-5A0E-4768-9E9B-0A5CAE9FFF0A

P1476

Q35995568-2B07050F-4BA1-45CA-B803-A49B84A9001F

P2093

Q35995568-02883485-78CA-4F52-B0BC-482660DE2D72

Q35995568-07FCCE16-B68B-4E59-8440-A7DE5BF22021

Q35995568-2016FF92-E4D0-471C-BCC5-A2685BAC3BA3

Q35995568-57BA5DE3-47E5-46C9-90ED-66AA2F6E9C2A

Q35995568-81697CA7-6977-4011-A936-9DFE386481BF

Q35995568-B4D7B208-0F72-4209-BFAC-C86853BF79E1

Q35995568-C4AC0F61-B45D-4F3C-992E-B69EA0A98132

Q35995568-CA581CC6-9AEB-4BBE-BF1E-9507200DE528

Q35995568-D187F797-9235-461F-939B-55250F862D3D

Q35995568-E3BA8FD1-ADD1-47ED-BF90-407ACAB56CF8

P2860

Q35995568-00116A98-8A43-46CC-AFE2-C8470EFA9B14

Q35995568-0B769786-6069-4DF5-A3A5-A34EFC571C4C

Q35995568-139451ED-EE1B-425F-BDB3-0D50518227F2

Q35995568-13E3C51F-7FD6-46EC-960E-72C35BDD8A94

Q35995568-14358EA2-6225-4F50-89E5-FFA29F08322A

Q35995568-14539C43-D900-4188-9DFD-B4D86249F461

Q35995568-28C83EF0-4C0E-4331-85DA-8C6FB91E4C6A

Q35995568-2BA4BE3D-7FE0-46F9-A7CF-975D6A6C4467

Q35995568-3DB73204-D42B-4565-B6C1-3D24BB9BB7A7

Q35995568-457A422A-F60E-4E89-88B9-BE244F81C83C

P304

Q35995568-428EF2E5-0D7C-4620-9D2B-C207B4194EF0

P31

Q35995568-60E74B42-AB31-4B81-87E5-A0615EDE7033

P433

Q35995568-A316AA6F-3AA3-4CFE-B085-1495482E0E95

P478

Q35995568-A3EB0E72-6122-443F-B5C8-3BEBFC2A437B

P577

Q35995568-35BD54E5-589B-4FE3-997A-C69D551DEBF3

P698

Q35995568-B937CDD7-6588-4956-B626-E254C7AFE474

P932

Q35995568-237D893F-71B1-4DEC-B367-A27644DBC3F7

P1433

P1476

Nightly treatment of primary i ...... of life, and work limitations.

@en

P2093

Andrew D Krystal

http://www.w3.org/2001/XMLSchema#string

David A Amato

http://www.w3.org/2001/XMLSchema#string

Gene Wallenstein

http://www.w3.org/2001/XMLSchema#string

James K Walsh

http://www.w3.org/2001/XMLSchema#string

James Roach

http://www.w3.org/2001/XMLSchema#string

Judy Caron

http://www.w3.org/2001/XMLSchema#string

Kendyl Schaefer

http://www.w3.org/2001/XMLSchema#string

Robert Rubens

http://www.w3.org/2001/XMLSchema#string

Thomas C Wessel

http://www.w3.org/2001/XMLSchema#string

Thomas Roth

http://www.w3.org/2001/XMLSchema#string

P2860

A new method for measuring daytime sleepiness: the Epworth sleepiness scale

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.

Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults.

National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.

Measuring outcomes in randomized clinical trials of insomnia treatments.

Insomnia and absenteeism at work. Who pays the cost?

Prevalence, burden, and treatment of insomnia in primary care.

The morbidity of insomnia uncomplicated by psychiatric disorders.

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.

P304

959-968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17702264

http://www.w3.org/2001/XMLSchema#string

P932

1978384

http://www.w3.org/2001/XMLSchema#string